4.5 Article

Monod-based 'single-data' strategy for biodegradation screening tests

期刊

ENVIRONMENTAL CHEMISTRY
卷 17, 期 3, 页码 278-288

出版社

CSIRO PUBLISHING
DOI: 10.1071/EN19171

关键词

chemical persistence; half-life; Monod model

资金

  1. Spanish Ministerio de Economia y Competitividad (MINECO) [CTQ2015-70904-R]
  2. European Regional Development Fund (ERDF) [CTQ2015-70904-R]
  3. Generalitat Valenciana [ACIF/2019/158]
  4. European Social Fund [ACIF/2019/158]

向作者/读者索取更多资源

Information obtained from biodegradability tests, e.g. half-life (t(50)) or kinetics parameters, is relevant in environmental risk assessment of new chemicals. In these tests, the removal of the tested compound is measured over a prefixed period of time (e.g. 28 days in ready biodegradability tests) to derive a substrate depletion curve. The implementation can be time-consuming, costly and difficult, especially when the complexity of the environmental compartment increases. In this work, the possibility of obtaining a full biodegradation depletion curve from a single biodegradation-time experimental data point ('single-data' strategy) was evaluated. Monod kinetics are assumed to avoid the limitations related to first-order kinetics (only valid for very low substrate concentrations). Experimental and simulated data were used to illustrate the potential of the proposed strategy. The effects on the estimates of several variables (e.g. Monod kinetics parameters, compound concentration or variability in biodegradation data) and the errors introduced to some of the variables were also evaluated. The results suggest that the proposed strategy can be used as a rapid (based on data measured at day 7) and low-cost screening approach to anticipate the result of a biodegradability test for new chemicals. The applicability and practical limitations of the 'single-data' strategy have been illustrated using experimental data for several compounds ranging from readily biodegradable (e.g. benzoic acid, acetylsalicylic acid, p-toluic acid) to potentially persistent compounds (e.g. bupivacaine, p-phenitidine, phtadinitrile).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据